Covered recipient · General Payments record
MONIFA DUKES
Physician Assistants & Advanced Practice Nursing Providers Advanced Practice Midwife
General Payments · PY2021–2024
$1,623.63
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $562.40 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $192.57 | 4 |
| Novo Nordisk AS | $124.74 | 1 |
| Organon LLC | $75.10 | 4 |
| Daiichi Sankyo Inc. | $48.95 | 2 |
| Exeltis, USA Inc. | $41.45 | 2 |
| SHIELD THERAPEUTICS INC | $33.78 | 1 |
| Medtronic, Inc. | $17.60 | 1 |
| PFIZER INC. | $17.56 | 1 |
| Aspira Women's Health Inc | $10.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aspira Women's Health Inc | $10.65 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126782170 | CMS |
| Astellas Pharma US Inc | $22.18 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139496958 | CMS |
| Astellas Pharma US Inc | $124.93 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139525806 | CMS |
| Astellas Pharma US Inc | $18.97 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139535788 | CMS |
| Astellas Pharma US Inc | $26.49 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139551599 | CMS |
| Daiichi Sankyo Inc. | $26.95 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089417460 | CMS |
| Daiichi Sankyo Inc. | $22.00 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089417458 | CMS |
| Exeltis, USA Inc. | $24.34 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150011497 | CMS |
| Exeltis, USA Inc. | $17.11 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150011499 | CMS |
| Medtronic, Inc. | $17.60 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116909983 | CMS |
| Novo Nordisk Inc | $124.74 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100235238 | CMS |
| Organon Llc | $23.74 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136205021 | CMS |
| Organon Llc | $14.19 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136205023 | CMS |
| Organon Llc | $22.66 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136205027 | CMS |
| Organon Llc | $14.51 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136205025 | CMS |
| PFIZER INC. | $17.56 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131626793 | CMS |
| SHIELD THERAPEUTICS INC | $33.78 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150148409 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.